Reverb Therapeutics

Reverb Therapeutics Develops Cytokine Therapy for Cancer Treatment and Targeted Immune Activation While Limiting Toxicity. The company uses bispecific antibodies to localize endogenous cytokines to immune cells within the tumor microenvironment (TME), overcoming the toxicity issues associated with exogenous cytokines, enabling cancer patients and healthcare providers to redirect already present endogenous cytokines in the body to target cells of interest for cancer treatment.